Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: IMMUNE CHECKPOINT INHIBITION, . Treffer: 7
2023
Suppan, C; Balic, M
Current standards and future outlooks in metastatic Her2-positive breast cancer
BREAST CARE. 2023;
Doi: 10.1159/000528756
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2022
Kocher, F; Puccini, A; Untergasser, G; Martowicz, A; Zimmer, K; Pircher, A; Baca, Y; Xiu, J; Haybaeck, J; Tymoszuk, P; Goldberg, RM; Petrillo, A; Shields, AF; Salem, ME; Marshall, JL; Hall, M; Korn, WM; Nabhan, C; Battaglin, F; Lenz, HJ; Lou, E; Choo, SP; Toh, CK; Gasteiger, S; Pichler, R; Wolf, D; Seeber, A
Multi-omic Characterization of Pancreatic Ductal Adenocarcinoma Relates CXCR4 mRNA Expression Levels to Potential Clinical Targets.
Clin Cancer Res. 2022; 28(22):4957-4967
Doi: 10.1158/1078-0432.CCR-22-0275
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Lindner, AK; Pichler, M; Thurnher, M; Pichler, R
Targeting c-Met to Improve Immune Checkpoint Inhibition in Metastatic Renal Cell Carcinoma.
Eur Urol. 2022; 81(1): 1-2.
Doi: 10.1016/j.eururo.2021.10.025
Web of Science
PubMed
FullText
FullText_MUG
2021
Semrau, S; Gostian, AO; Traxdorf, M; Eckstein, M; Rutzner, S; von, der, Grün, J; Illmer, T; Hautmann, M; Klautke, G; Laban, S; Brunner, T; Tamaskovics, B; Frey, B; Zhou, JG; Geppert, CI; Hartmann, A; Balermpas, P; Budach, W; Gaipl, U; Iro, H; Fietkau, R; Hecht, M
Implementation of Double Immune Checkpoint Blockade Increases Response Rate to Induction Chemotherapy in Head and Neck Cancer.
Cancers (Basel). 2021; 13(8):
Doi: 10.3390/cancers13081959
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Walsh, NM; Cerroni, L
Merkel cell carcinoma: A review.
J Cutan Pathol. 2021; 48(3):411-421
Doi: 10.1111/cup.13910
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2020
Luecke, E; Ganzert, C; Vielhaber, S; Haybaeck, J; Jechorek, D; Mawrin, C; Schreiber, J
Immune Checkpoint Inhibitor-induced Fatal Myositis in a Patient With Squamous Cell Carcinoma and a History of Thymoma.
Clin Lung Cancer. 2020; 21(4):e246-e249-e246-e249
Doi: 10.1016/j.cllc.2020.01.008
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Riedl, JM; Barth, DA; Brueckl, WM; Zeitler, G; Foris, V; Mollnar, S; Stotz, M; Rossmann, CH; Terbuch, A; Balic, M; Niedrist, T; Bertsch, T; Stoeger, H; Pichler, M; Olschewski, H; Absenger, G; Ficker, JH; Gerger, A; Posch, F
C-Reactive Protein (CRP) Levels in Immune Checkpoint Inhibitor Response and Progression in Advanced Non-Small Cell Lung Cancer: A Bi-Center Study.
Cancers (Basel). 2020; 12(8):
Doi: 10.3390/cancers12082319
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG